Biostax Corp (BTAX)

[locicat1]

First of all the correct term as announced is an acquisition by IMUN of Aletheia Therapeutics Corp. in an all-stock transaction. If indeed that has been accomplished then not just an announcement of such completion but an SEC 8-K filing would certainly be required as the acquisition would be a material event. Secondly, if indeed the acquisition has been completed as shareholders we need to know what the exact parameters are regarding the stock quantity involved and what IMUN is exactly acquiring.